Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone.
Koutsostathis
N
N
Department of Allergy and Clinical Immunology, Laiko General Hospital, Athens, Greece.
Vovolis
V
V
D000284:Administration, Oral; D000328:Adult; D000707:Anaphylaxis / Q000276:immunology; D000799:Angioedema; D001986:Bronchial Spasm; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000503:physiopathology; D000939:Epitopes; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology / Q000378:metabolism*; D007275:Injections, Intravenous / Q000009:adverse effects; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives; D011537:Pruritus; D012882:Skin Tests
D000939:Epitopes; D007073:Immunoglobulin E; D008776:Methylprednisolone Hemisuccinate